Agios Pharmaceuticals Market Cap 2012-2019 | AGIO
Agios Pharmaceuticals market cap history and chart from 2012 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Agios Pharmaceuticals market cap as of August 16, 2019 is $2.5B.
||Medical Products Manufacturing
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.